The malaria crisis is starting to yield to new tools and strategies, made possible by a substantial bump in funds - from less than $100 million in the late 1990s to almost $1 billion for 2008. The current goal is to reduce malaria deaths by half, worldwide, by 2010. Can this wad of cash strike the killer blow?
For years the global malaria effort has been asking for more resources. Now the field needs to figure out a systematic strategy for spending the money effectively, says Mark Grabowsky.
After decades of work, a pioneering malaria vaccine may soon reach the final phase of clinical trials. In the first of two features on efforts against malaria, Brendan Maher reports on a vaccine that is far from perfect — but which may provide new direction and save thousands of lives.